224 top medical experts on Diffuse Cerebral Sclerosis of Schilder across 37 countries and 14 U.S. states, including 51 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Diffuse Cerebral Sclerosis of Schilder: A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Brain Diseases (4,643), CNS Demyelinating Autoimmune Diseases (1,416).
  4. Clinical Trials ClinicalTrials.gov : at least 3 including 1 Recruiting
  5. Synonyms: Alpers Syndrome,  Balo Concentric Sclerosis,  Diffuse Cerebral Sclerosis,  Encephalitis Periaxialis,  Myelinoclastic Diffuse Sclerosis,  Poliodystrophia Cerebri,  Schilder Disease


  

        

                    


    Computing Expert Listing ...

);